Market Place
Sourcing Support
GeoVax, ABL Partner to Advance cGMP Production of Vaccine Candidates
31 May 2023 //
CONTRACT PHARMA
GeoVax and EmVenio partner for clinical facility to expand Covid-19 trial
15 Feb 2023 //
CLINICAL TRIALS ARENA
GeoVax expands Gedeptin clinical research for advanced head and neck cancers
09 Feb 2023 //
PHARMABIZ
USPTO Issues Malaria Vaccine Patent to GeoVax
28 Apr 2022 //
PHARMTECH
GeoVax engages CRO CATO SMS for two Phase II Covid-19 vaccine trials
15 Mar 2022 //
CLINICALTRIALSARENA
Lancet Journal: COH04S1 Produces Robust Ab and T Cells Against SARS-CoV-2
10 Mar 2022 //
BUSINESSWIRE
GeoVax commences dosing in Covid-19 booster shot trial
16 Dec 2021 //
CLINICALTRIALSARENA
GeoVax Labs Shares Jump After Presenting COVID-19 Vaccine Data at EU Meeting
20 Aug 2021 //
FIRSTWORD PHARMA
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine DevP
26 Oct 2020 //
PRESS RELEASE
GeoVax closes $12.8M capital raise
30 Sep 2020 //
SEEKING ALPHA
GeoVax Announces Pricing of $12.8M Public Offering
25 Sep 2020 //
SEEKING ALPHA
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data
03 Sep 2020 //
GLOBENEWSWIRE
GeoVax & Sino Biological Establish Exclusive Supply Agreement for Research Grade
30 Apr 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.